Search

Search Constraints

You searched for: Author/Creator Robieson, Weining Z.

Search Results

3. A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies. (2020)

4. Device Complaints and Longevity of PEG‐J Used for Continuous Infusion of Levodopa‐Carbidopa Intestinal Gel in Ambulatory Patients With Parkinson's Disease: 1507. (October 2015)

5. DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease. Issue 7 (12th September 2021)

6. Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study. (4th November 2022)

7. Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials. Issue 4 (23rd December 2015)

8. Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results. Issue 4 (24th December 2014)

9. Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease. Issue 6 (23rd March 2018)

10. O1‐02‐06: ABBV‐8E12, A HUMANIZED ANTI‐TAU MONOCLONAL ANTIBODY FOR THE TREATMENT OF EARLY ALZHEIMER'S DISEASE: STUDY DESIGN AND BASELINE CHARACTERISTICS FOR A 96‐WEEK, MULTIPLE DOSE, RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2 STUDY. (1st July 2006)